HOME / ENTER FOR 2017 / CATEGORIES

Categories

1. Excellence in Pharma: API Development
Innovation in technologies, products, processes, and services for the development and manufacture of active pharmaceutical ingredients (APIs) including, but not limited to, synthesis, characterization, formulation, scale-up, software and database development, and bulk manufacturing.
2. Excellence in Pharma: Formulation
Innovation in technologies, products, processes, and services related to the formulation of drug products including, but not limited to, excipients, novel software and databases, process development, resolving formulation challenges such as solubility/bioavailability enhancement, drug targeting or controlled release, solving stability issues such as protein aggregation, etc.
3. Excellence in Pharma: Excipients
Innovations in inactive pharmaceutical ingredients to improve the manufacturing process or the formulation, including, but not limited to stability, solubility, taste masking, controlled release, or other factors.
4. Excellence in Pharma: Manufacturing Technology and Equipment
Innovation in technologies, products, processes, and services for the manufacture of solid, semi-solid, parenteral, inhalation, or other dosage drugs including, but not limited to, equipment, manufacturing processes, facilities, process controls, and continuous manufacturing.
5. Excellence in Pharma: Bioprocessing
Innovation in technologies, products, processes, and services for the manufacture of biologic-based drugs including, but not limited to, equipment, raw materials, cell lines, manufacturing processes, facilities, process controls, and continuous manufacturing.
6. Excellence in Pharma: Analysis, Testing, and Quality Control
Innovation in technologies, products, processes, and services for the analysis and testing of drug substances, raw materials, and drug products in a laboratory on production line setting including, but not limited to, laboratory instruments and equipment, analytical instruments, laboratory software, quality control tools, data integrity systems, and contract laboratory services.
7. Excellence in Pharma: Drug Delivery Devices
Innovation in technologies, products, processes, and services related delivery of drug products to patients including, but not limited to, inhalers, auto-injectors, vials, syringes, patches, and combination products.
8. Excellence in Pharma: Packaging
Innovation in technologies, products, processes, and services related to primary and secondary packaging for finished drug forms including, but not limited to, tamper-proof packaging, child-safety packaging, labeling, intelligent packaging, and fill-finish.
9. Excellence in Pharma: Supply Chain, Logistics, and Distribution
Innovation in technologies, products, processes, and services for ensuring the safe handling and tracking of drug substances, raw materials, and finished drug products including, but not limited to, logistics, cold chain, transport services, track and trace, shipping containers, and distribution channels.
10. Excellence in Pharma: Contract Services and Outsourcing
Innovation in contracted services and processes for the bio/pharmaceutical industry including, but not limited to, drug research, development, formulation, scale up, process development, clinical trial manufacturing, drug product manufacturing, API development and manufacturing, laboratory services, and consulting.
11. Excellence in Pharma: Regulatory Procedures and Compliance
Innovation in technologies, products, processes, and services designed to aid and ensure that bio/pharma companies comply with compendial standards, rules, and guidance documents established by regulatory authorities including, but not limited to, consulting services, development of consortia and industry groups, reference standards, educational programs, and software and IT, technologies, and equipment.
12. Excellence in Pharma: Corporate Social Responsibility
This award recognizes innovation in improving transparency and public outreach, recognizing new programs including, but not limited to, charitable work, sustainable sourcing, environmental protection, staff reward policies, drug access schemes for patients, training/mentoring programs, responsible sourcing, fair employee pay/ethical working policies.
13. Excellence in Pharma: CEO of the Year
The chief executive officer of an innovator or generic-drug company is eligible for nomination. Attributes to be considered include, but are not limited to, financial performance, product performance, global reach, leadership skills, management capability, charity initiatives, regulatory compliance, profitability, vision, marketing, acquisitions, corporate strategy, and financing. Note: This category is limited to bio/pharma companies.
14. Excellence in Pharma: Pharma Company of the Year – Large
This category is open to any large bio / pharmaceutical company that develops, produces, and markets drugs or pharmaceuticals. We define a large company as one with over 250 employees.
15. Excellence in Pharma: Pharma Company of the Year – SME
This category is open to any small and medium-sized (SME) bio / pharmaceutical company that develops, produces and markets drugs or (bio) pharmaceuticals. We define a SME company as one with up to 249 employees.
16. Excellence in Pharma: Sustainability Initiative of the Year
This category recognizes sustainable development in the pharmaceutical industry through innovative and sustainable use of resources and prioritizes the needs of the wider environment and society.
17. Excellence in Pharma: Export Promotion
This category recognizes pharma companies that has seen a significant growth in export turnover year-on-year in % terms.
18. Excellence in Pharma: OTC
This category recognizes the process of developing the drug, but not the properties of a drug product. The category is limited to drug products that are subject to regulatory review.
19. Excellence in Pharma: Patient Centricity
Innovation in technologies, products, processes, and services related delivery of drug products to patients. But this category especially recognizes the attention and care for improved patient wellbeing.
20. Excellence in Pharma: IT, mHealth & Digitilisation
This category recognizes pharma companies that are making steps towards offering a range of services that support patient compliance, adherence or interdisciplinary collaboration. But also innovations like measuring the real-life effects of medicines or fully integrated services that will improve the quality and efficiency of care.